Omnicell delivers solid third quarter 2026 financial results
Updates full year 2026 guidance
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," or the "Company"), a healthcare
Omnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the third quarter 2026, before market open on
Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes.BOSTON, Sept.
Omnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Wells Fargo 21st Annual Healthcare Conference on
New solution may help pharmacies grow monthly vaccinations by up to 66%1
EnlivenHealth, Inc., a subsidiary of Omnicell, Inc. ("EnlivenHealth") and a leading innovator in pharmacy technology and patient
Omnicell delivers solid second quarter 2026 financial results
Updates full year 2026 guidance
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," or the "Company"), a leading
Omnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the second quarter 2026, before market open on
Njoku continues to lead global operations and advance Omnicell's innovation and AI platform strategy; Randall Lipps continues to serve as Chief Executive Officer and Chairman of the Board
Omnicell, Inc.
Seasoned healthcare executive with deep expertise in specialty pharmacy operations named Senior Vice President and General Manager
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leading healthcare
Omnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Goldman Sachs 47th Annual Global Healthcare Conference
Omnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the BofA Securities 2026 Healthcare Conference on Tuesday,
Newly established role strengthens understanding of healthcare clinician needs to help shape the Company's innovation priorities and portfolio decisions
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a
Omnicell delivers strong first quarter 2026 financial results
Raises full year 2026 non-GAAP EBITDA and non-GAAP EPS guidance
Customer engagement underway for Omnicell Titan XT and OmniSphere
Omnicell, Inc.
Omnicell, Inc. (NASDAQ:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the first quarter 2026, before market open on
